Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 149 of the 150 references it cites were found in a registry or an index.

Natural history and progression of metabolic dysfunction-associated steatotic liver disease

Hagström, Hannes, Shang, Ying, Hegmar, Hannes, Nasr, Patrik · 2024 · The Lancet Gastroenterology & Hepatology

Abstract

The natural history of metabolic dysfunction-associated steatotic liver disease (MASLD), previously referred to as non-alcoholic fatty liver disease (NAFLD), is complex and long. A minority of patients develop inflammation and risk progressive fibrosis that can result in cirrhosis. Progression to cirrhosis occurs in 3-5% of patients and often takes more than 20 years. This narrative review presents an update on the natural history of MASLD, discussing studies and risk estimates for progression to severe outcomes, such as decompensated cirrhosis or hepatocellular carcinoma. We highlight the dynamic progression of liver damage, how to identify patients whose disease progresses over time, and how risk factors might be mitigated to reduce the risk for disease progression.

Overview

Integrity signals

Registry

Crossref · 10.1016/s2468-1253(24)00193-6

Cites

149 of 149 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 150 references

Research works printed but not linked: 2

  1. Vilar-Gomez, 2018, Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study, Gastroenterology, 155, 443, 10.1053/j.gastro.2018.04.034 · DOI · Paper page
  2. Dulai, 2017, Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis, Hepatology, 65, 1557, 10.1002/hep.29085 · DOI · Paper page

Cited by

See all 310

Metadata

Authors
Hagström, H., Shang, Y., Hegmar, H., & Nasr, P.
Affiliations
  • Karolinska University Hospital (SE)
  • Karolinska Institutet (SE)
  • Linköping University (SE)
Corresponding author
Hagström, Hannes
Venue
The Lancet Gastroenterology & Hepatology
Publisher
Elsevier BV
Published
2024-10
Volume
9
Issue
10
Pages
944-956
ISSN
  • 2468-1156 (ISSN-L)
  • 2468-1253
OpenAlex
W4402210752
Cited by
310
References
150
Citations by year
2026: 160 · 2025: 136 · 2024: 14
FWCI
20.37
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet. Gastroenterology & hepatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords
non-alcoholic fatty liver disease, natural history (disease), disease progression, liver fibrosis, liver cirrhosis, decompensated cirrhosis, hepatocellular carcinoma, liver inflammation, risk factors
MeSH terms
Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Liver Neoplasms, Risk Factors, Disease Progression, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Natural history and progression of metabolic dysfunction-associated steatotic liver disease. https://app.cochat.ai/papers/10.1016/s2468-1253(24)00193-6
The paper
Hagström, H., Shang, Y., Hegmar, H., & Nasr, P. (2024). Natural history and progression of metabolic dysfunction-associated steatotic liver disease. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(24)00193-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.